阿斯特雷昂纳姆-阿维巴克坦:对抗多药耐药格拉姆阴性病原体的动态二人组.
Mohammed Al Musawa1, Callan R Bleick1, Shelbye R Herbin2,3
1Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
Pharmacotherapy
|November 27, 2024
概括
阿兹特雷诺姆-阿维巴克坦 (ATM-AVI) 提供了一种新的治疗方法,用于困难的грам阴性感染. 这种组合疗法对多种耐药细菌有效,包括那些产生卡巴酶的细菌.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 抗菌素耐药性 (AMR) 是一个主要的全球健康威胁,特别是耐卡巴胺的格拉姆阴性感染.
- 金属β-乳酸酶 (MBLs) 越来越令人担忧,它们对许多抗生素产生了耐药性.
- 阿兹特雷诺姆-阿维巴克坦 (ATM-AVI) 是一种新的组合疗法,旨在应对这些挑战.
研究的目的:
- 审查aztreonam-avibactam的化学成分,作用机制和临床应用.
- 评估ATM-AVI对抗多药耐药 (MDR) 格拉姆阴性病原体的疗效和安全性.
- 突出ATM-AVI作为严重感染的治疗选择.
主要方法:
- 对ATM-AVI.现有研究的文献综述.
- 在体外和临床试验数据的分析 (例如,REVISIT,ASSEMBLE).
- 对药理动力学和药理动力学性质的检查.
主要成果:
- ATM-AVI证明了对MDR格兰氏阴性细菌的广泛活性,包括MBL生产者.
- 临床试验表明,ATM-AVI对复杂的腹内感染,尿道感染和HAP安全有效.
- 药理动力学数据支持适当的剂量,并根据功能障碍进行调整.
结论:
- 阿兹特雷诺姆-阿维巴克坦是一种重要的新疗法,用于挑战MDR格兰氏阴性细菌引起的感染.
- ATM-AVI在打击抗微生物药物耐药性方面提供了急需的治疗进展.
- 进一步的研究旨在优化其使用并扩大临床应用.
关键词:
进入细菌体中的细菌.抗微生物耐药性 抗微生物耐药性这就是Avibactam.阿兹特里奥纳姆的母亲碳烯质量质量问题格拉姆阴性细菌是一种细菌.金属-β-乳酸酶的使用.莫诺巴克坦 (Monobactam) 是一种药物.更多相关视频
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
534
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
1.5K
相关概念视频
Antimicrobial Effectiveness
2
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
